StockData
Danaher Corp logo

Danaher Corp

DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3025% above fair value
$232.23−4.75 (-2.00%)

Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –

Danaher Biotechnology by Quarter

Biotechnology — Recurring Revenue (Recurring: Chromatography Resins, Filtration Membranes, Cell Culture Media) ($M)

QuarterlyAnnual

Danaher Biotechnology: $1,584M in Q3 2026, down 0.4% from a year earlier.

Latest, Q3 2026
1,584
Period ended Sep 30, 2026
Change on a year earlier
-0.4%
1,590 in Q3 2025
History
15 quarters
Since Q1 2023
Sources
10
Documents cited below

Where the Q3 2026 figure comes from

Source: Danaher SEC 10-Q (2026Q3, filed 2026-10-21) ↗

2-dimensional revenue breakdown in Revenue Disclosures (Note 3 / Note 6, continuing operations basis following the Veralto spin-off); Q4 is calculated as Full Year (10-K) minus 9-month (10-Q Q3).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedBiotechnology — Recurring Revenue (Recurring: Chromatography Resins, Filtration Membranes, Cell Culture Media) ($M)Year on yearSource
Q3 2026Sep 30, 20261,584-0.4%Danaher SEC 10-Q (2026Q3, filed 2026-10-21) ↗
Q2 2026Jun 30, 20261,722+1.7%Danaher SEC 10-Q (2026Q2, filed 2026-07-21) ↗
Q1 2026Mar 31, 20261,642+12.7%Danaher SEC 10-Q (2026Q1, filed 2026-04-21) ↗
Q4 2025Dec 31, 20251,683+8.7%Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗
Q3 2025Sep 30, 20251,590+11.8%Danaher SEC 10-Q (2026Q3, filed 2026-10-21) ↗
Q2 2025Jun 30, 20251,694+14.6%Danaher SEC 10-Q (2026Q2, filed 2026-07-21) ↗
Q1 2025Mar 31, 20251,457+11.3%Danaher SEC 10-Q (2026Q1, filed 2026-04-21) ↗
Q4 2024Dec 31, 20241,549+6.0%Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗
Q3 2024Sep 30, 20241,422+2.3%Danaher SEC 10-Q (2025Q3, filed 2025-10-21) ↗
Q2 2024Jun 30, 20241,478-3.7%Danaher SEC 10-Q (2025Q2, filed 2025-07-22) ↗
Q1 2024Mar 31, 20241,309-13.4%Danaher SEC 10-Q (2025Q1, filed 2025-04-22) ↗
Q4 2023Dec 31, 20231,462–Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗
Q3 2023Sep 30, 20231,390–Danaher SEC 10-Q (2024Q3, filed 2024-10-22) ↗
Q2 2023Jun 30, 20231,534–Danaher SEC 10-Q (2024Q2, filed 2024-07-23) ↗
Q1 2023Mar 31, 20231,511–Danaher SEC 10-Q (2024Q1, filed 2024-04-23) ↗

Cite this data

StockData. (2026). Danaher Biotechnology ($M), quarterly Q1 2023–Q3 2026 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/disagg-biotech-type-recurring

See every metric in the Danaher KPI table. Data updated Nov 2, 2026.